Pfizer Inc.

NYS : PFE
Pharmaceuticals
New York NY
IW Best50N/A
2012 Revenue (US$ Millions)$58,986
2011 Revenue (US$ Millions)$67,425
Revenue Growth (%)-12.52%
Net Income (US$ Millions)$14,570
Common Shares Outstanding (Millions)$7,276
Earnings Per Share (US$)$1.94
Total Equity (US$ Millions)$81,260
Profit Growth (%)45.57
Profit Margin (%)24.70%
Return On Equity (%)17.73%
Long Term Debt (US$ Millions)$31,036
Debt To Equity Ratio (%)0.38%
Market Capitalization (US$ Millions)$182,477
Total Assets (US$ Millions)$185,798
Return on Assets (%)7.75
Current Assets (US$ Millions)$61,415
Inventories (US$ Millions)$7,063
Current Liabilities (US$ Millions)$28,619
Cost of Goods Sold (US$ Millions)$11,334
Asset Turnover0.32
Inventory Turnover1.53